nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.00281	0.00281	CcSEcCtD
Ceftaroline fosamil—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.00277	0.00277	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.00273	0.00273	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00271	0.00271	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00269	0.00269	CcSEcCtD
Ceftaroline fosamil—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00267	0.00267	CcSEcCtD
Ceftaroline fosamil—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00264	0.00264	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00262	0.00262	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Ceftaroline fosamil—Pain—Stavudine—acquired immunodeficiency syndrome	0.00258	0.00258	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00257	0.00257	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00257	0.00257	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00255	0.00255	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Ceftaroline fosamil—Pain—Abacavir—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Ceftaroline fosamil—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Ceftaroline fosamil—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Rash—Amprenavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00237	0.00237	CcSEcCtD
Ceftaroline fosamil—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00235	0.00235	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00235	0.00235	CcSEcCtD
Ceftaroline fosamil—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00224	0.00224	CcSEcCtD
Ceftaroline fosamil—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00224	0.00224	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00224	0.00224	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00222	0.00222	CcSEcCtD
Ceftaroline fosamil—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00222	0.00222	CcSEcCtD
Ceftaroline fosamil—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Rash—Didanosine—acquired immunodeficiency syndrome	0.00219	0.00219	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00219	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00219	0.00219	CcSEcCtD
Ceftaroline fosamil—Headache—Didanosine—acquired immunodeficiency syndrome	0.00218	0.00218	CcSEcCtD
Ceftaroline fosamil—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Ceftaroline fosamil—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00212	0.00212	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00211	0.00211	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.0021	0.0021	CcSEcCtD
Ceftaroline fosamil—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.0021	0.0021	CcSEcCtD
Ceftaroline fosamil—Pain—Indinavir—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Ceftaroline fosamil—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Ceftaroline fosamil—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Ceftaroline fosamil—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00207	0.00207	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00207	0.00207	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00207	0.00207	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00203	0.00203	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00203	0.00203	CcSEcCtD
Ceftaroline fosamil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00194	0.00194	CcSEcCtD
Ceftaroline fosamil—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00194	0.00194	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00193	0.00193	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00193	0.00193	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00191	0.00191	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Rash—Stavudine—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Headache—Stavudine—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Rash—Abacavir—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Headache—Abacavir—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Ceftaroline fosamil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00176	0.00176	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00176	0.00176	CcSEcCtD
Ceftaroline fosamil—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00165	0.00165	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00165	0.00165	CcSEcCtD
Ceftaroline fosamil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00164	0.00164	CcSEcCtD
Ceftaroline fosamil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Pain—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Ceftaroline fosamil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Rash—Indinavir—acquired immunodeficiency syndrome	0.00154	0.00154	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00153	0.00153	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00153	0.00153	CcSEcCtD
Ceftaroline fosamil—Headache—Indinavir—acquired immunodeficiency syndrome	0.00153	0.00153	CcSEcCtD
Ceftaroline fosamil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00151	0.00151	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00148	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00148	CcSEcCtD
Ceftaroline fosamil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Ceftaroline fosamil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Ceftaroline fosamil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0014	0.0014	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00138	0.00138	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00138	CcSEcCtD
Ceftaroline fosamil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.00132	CcSEcCtD
Ceftaroline fosamil—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Ceftaroline fosamil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00125	CcSEcCtD
Ceftaroline fosamil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Ceftaroline fosamil—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Ceftaroline fosamil—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
